Cite

HARVARD Citation

    Chugh, S. et al. (2015). Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. Lancet. 2 (2), pp. e75-e81. [Online]. 
  
Back to record